Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000093

Chief Executive Officer sold 11,085 shares at $36.67 ($406,487)

  • Chief Executive Officer acquired 22,691 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-08 Exercise or conversion : show line 1 in the form 10b5-1 +22,691 134,613 D
2025-08-08 Sale : show line 2 in the form 10b5-1 −11,085 $36.67 $406,487 123,528 D
Open-market sales · 11,085 sh · avg $36.67 · $406,487

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-08 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −22,691 0 D
Loading xslF345X05/wk-form4_1755030260.xml…